# Efficacy and Safety of Modified Si Jun Zi Tang in Perioperative NSCLC Treatment

> **NCT06445881** · PHASE2 · RECRUITING · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 60 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer
- Perioperative Complication

## Interventions

- **DRUG:** Modified Si Jun Zi Tang

## Key facts

- **NCT ID:** NCT06445881
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06445881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06445881, "Efficacy and Safety of Modified Si Jun Zi Tang in Perioperative NSCLC Treatment". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06445881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*